Immunogenetics of Henoch-Schoenlein disease

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• Henoch-Schoenlein purpura (HS) is a systemic vasculitis often associated with immune dysregulation.
• The genetic underpinnings of HS susceptibility, particularly in relation to human leukocyte antigen (HLA) genes, require further elucidation.

Purpose of the Study:

• To investigate the genetic basis of susceptibility to Henoch-Schoenlein purpura (HS).
• To identify specific HLA alleles associated with HS risk and potential protective effects.

Main Methods:

• Blood samples from 152 HS patients and controls were analyzed for HLA-DRB, DQB, and DQA polymorphism using TaqI restriction enzyme analysis.
• Polymerase chain reaction-sequence-specific oligonucleotide (PCR-SSO) typing was employed for detailed analysis of specific HLA-DRB subtypes.
• Immunoglobulin heavy chain switch region polymorphisms were also examined using SacI enzyme.

Main Results:

• The HLA allele DRB1*07 was significantly less frequent in HS patients compared to controls (P=0.0023).
• Conversely, DRB1*01 and/or DRB1*11 alleles were more prevalent in patients (64%) than in controls (48%) (P=0.0069).
• Among DRB1*11 subtypes, DRB1*1104 showed a significant increase in patients (Pc=0.033). No significant differences were observed in patients with or without renal disease, nor in immunoglobulin gene polymorphisms.

Conclusions:

• Susceptibility to Henoch-Schoenlein purpura has a genetic component, linked to specific HLA-DRB alleles.
• The presence of DRB1*01 or DRB1*11 appears to predispose individuals to HS, while DRB1*07 may confer resistance.
• Amino acid variations within the HLA-DRB molecule likely influence the recognition of specific antigenic peptides, triggering the immune response leading to HS.